Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism HBV capsid modulators(HBV capsid modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H17F4N3O4S |
InChIKeyVPVGGXRVWGBGDZ-UHFFFAOYSA-N |
CAS Registry2411762-66-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B | Preclinical | KR | 09 Jan 2020 |